G.S. Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 5.48 Cr
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.20 Cr
- Satisfied Charges ₹ 33.19 Cr
- Revenue Growth 116.56%
- Profit Growth 96.64%
- Ebitda 42.14%
- Net Worth 14.66%
- Total Assets 42.35%
About G.S. Pharmaceuticals
G.S. Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 October 1985 and has a history of 39 years and four months. Its registered office is in Muzaffarnagar, Uttar Pradesh, India.
The Corporate was formerly known as G. S. Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.48 Cr.
The company currently has active open charges totaling ₹40.20 Cr. The company has closed loans amounting to ₹33.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Arora, Alpana Arora, Dolly Arora, and Three other members serve as directors at the Company.
Company Details
-
Location
Muzaffarnagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24111UP1985PTC007454
-
Company No.
007454
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 1985
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at G.S. Pharmaceuticals?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Arora
|
Director | 09-Nov-2019 | Current |
|
Alpana Arora
|
Director | 09-Nov-2019 | Current |
|
Dolly Arora
|
Director | 09-Nov-2019 | Current |
|
Prashant Arora
|
Director | 09-Sep-1995 | Current |
|
Vivek Arora
|
Director | 10-Oct-1985 | Current |
|
Anurag Arora
|
Director | 10-Oct-1985 | Current |
Financial Performance of G.S. Pharmaceuticals.
G.S. Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 116.56% increase. The company also saw a substantial improvement in profitability, with a 96.64% increase in profit. The company's net worth Soared by an impressive increase of 14.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G.S. Pharmaceuticals?
In 2019, G.S. Pharmaceuticals had a promoter holding of 46.06% and a public holding of 53.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹40.20 Cr
₹33.19 Cr
Charges Breakdown by Lending Institutions
- Others : 32.20 Cr
- Icici Bank Limited : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2021 | Others | ₹29.00 Cr | Open |
| 31 Dec 2019 | Others | ₹3.20 Cr | Open |
| 31 Dec 2013 | Icici Bank Limited | ₹8.00 Cr | Open |
| 25 Jan 2011 | Oriental Bank Of Commerce | ₹14.00 Cr | Satisfied |
| 25 Sep 2009 | Canara Bank | ₹1.00 Cr | Satisfied |
How Many Employees Work at G.S. Pharmaceuticals?
G.S. Pharmaceuticals has a workforce of 3 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.S. Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.S. Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
